Search details
1.
Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-Factor analysis.
Allergy
; 78(11): 2933-2943, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37458287
2.
Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer: comparison of diagnostic performances of dedicated breast PET, whole-body PET, and dynamic contrast-enhanced MRI.
Breast Cancer Res Treat
; 188(1): 107-115, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33730265
3.
Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302.
Int J Clin Oncol
; 26(3): 515-522, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33184754
4.
Safety and efficacy of first-line dacomitinib in Japanese patients with advanced non-small cell lung cancer.
Cancer Sci
; 111(5): 1724-1738, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32159882
5.
Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer.
Oncologist
; 25(6): 475-e891, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31649134
6.
Survival Analysis for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401.
Oncologist
; 25(4): 306-e618, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32297438
7.
Mitigation of Memory Impairment in Ovariectomized Rats Using Garlic Powder Treated with Subcritical Water.
Biol Pharm Bull
; 43(3): 546-549, 2020.
Article
in English
| MEDLINE | ID: mdl-32115513
8.
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial.
Lancet Oncol
; 20(5): 625-635, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30975627
9.
Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702).
Oncologist
; 24(11): e1172-e1179, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31068386
10.
Peptide TNIIIA2 Derived from Tenascin-C Contributes to Malignant Progression in Colitis-Associated Colorectal Cancer via ß1-Integrin Activation in Fibroblasts.
Int J Mol Sci
; 20(11)2019 Jun 05.
Article
in English
| MEDLINE | ID: mdl-31195598
11.
A phase I/II trial of pemetrexed plus radiotherapy in elderly patients with locally advanced non-small cell lung cancer.
Invest New Drugs
; 36(4): 667-673, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29572782
12.
Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301.
Oncologist
; 22(6): 640-e59, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28526722
13.
Evaluation of a Quantitative Serological Assay for Diagnosing Chronic Pulmonary Aspergillosis.
J Clin Microbiol
; 54(6): 1496-1499, 2016 06.
Article
in English
| MEDLINE | ID: mdl-27008878
14.
Microbiota-derived acetylcholine can promote gut motility in Drosophila melanogaster.
Philos Trans R Soc Lond B Biol Sci
; 379(1901): 20230075, 2024 May 06.
Article
in English
| MEDLINE | ID: mdl-38497270
15.
Incidence of nausea/vomiting following propofol sedation with adaptive servo-ventilation for atrial fibrillation ablation.
J Arrhythm
; 40(2): 289-296, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38586848
16.
A phase II study of amrubicin as a third-line or fourth-line chemotherapy for patients with non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901.
Oncologist
; 18(4): 439-45, 2013.
Article
in English
| MEDLINE | ID: mdl-23442308
17.
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.
N Engl J Med
; 362(25): 2380-8, 2010 Jun 24.
Article
in English
| MEDLINE | ID: mdl-20573926
18.
Clinical benefit of platinum doublet combination therapy in older adults with advanced non-small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan.
Thorac Cancer
; 14(17): 1597-1605, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37073452
19.
Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL Study.
JTO Clin Res Rep
; 4(6): 100514, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37304652
20.
[Measurement as a Personal Dose Equivalent of X-ray Room Scattered Dose in ERCP Inspection].
Nihon Hoshasen Gijutsu Gakkai Zasshi
; 78(4): 364-371, 2022 Apr 20.
Article
in Japanese
| MEDLINE | ID: mdl-35296572